Abstract
Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Current Respiratory Medicine Reviews
Title:Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Volume: 12 Issue: 1
Author(s): Arthur L. Frank
Affiliation:
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Abstract: Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Export Options
About this article
Cite this article as:
Frank L. Arthur, Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151026222515
DOI https://dx.doi.org/10.2174/1573398X11666151026222515 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Interventions for the Prevention and Treatment of Kidney
Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical
Perspectives
Current Molecular Pharmacology Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems
Current Pharmaceutical Design Cucurbitacin B Induces DNA Damage, G2/M Phase Arrest, and Apoptosis Mediated by Reactive Oxygen Species (ROS) in Leukemia K562 Cells
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer
Combinatorial Chemistry & High Throughput Screening Chemotherapy for Laryngeal Cancer - An Apoptotic Approach
Current Drug Targets Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent
Anti-Cancer Agents in Medicinal Chemistry Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Current Medicinal Chemistry How Inhaled Asbestos Causes Scarring and Cancer
Current Respiratory Medicine Reviews Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update
Current Pharmaceutical Design CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Editorial from Editor-in-Chief
Current Respiratory Medicine Reviews The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Current Medicinal Chemistry Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Medical Expert Systems
Current Bioinformatics Regulative Roles of Ghrelin in Ingestive Behavior, Upper Gastrointestinal Motility, and Secretion
Current Nutrition & Food Science The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Trends and Topics in CD133 in Pubmed From 2000 to 2015
Current Biomarkers (Discontinued)